- Home
- PROK vs SUNS Comparison
PROK vs SUNS Comparison
Compare PROK & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- SUNS
- Stock Information
- Founded
- PROK 2015
- SUNS 2023
- Country
- PROK United States
- SUNS United States
- Employees
- PROK N/A
- SUNS N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- SUNS Real Estate Investment Trusts
- Sector
- PROK Health Care
- SUNS Real Estate
- Exchange
- PROK Nasdaq
- SUNS Nasdaq
- Market Cap
- PROK 126.8M
- SUNS 148.2M
- IPO Year
- PROK N/A
- SUNS N/A
- Fundamental
- Price
- PROK $0.60
- SUNS $9.67
- Analyst Decision
- PROK Buy
- SUNS Strong Buy
- Analyst Count
- PROK 4
- SUNS 3
- Target Price
- PROK $5.00
- SUNS $13.92
- AVG Volume (30 Days)
- PROK 410.9K
- SUNS 169.4K
- Earning Date
- PROK 05-09-2025
- SUNS 03-06-2025
- Dividend Yield
- PROK N/A
- SUNS 8.76%
- EPS Growth
- PROK N/A
- SUNS N/A
- EPS
- PROK N/A
- SUNS 1.00
- Revenue
- PROK $76,000.00
- SUNS $10,588,270.00
- Revenue This Year
- PROK N/A
- SUNS $141.80
- Revenue Next Year
- PROK N/A
- SUNS $53.98
- P/E Ratio
- PROK N/A
- SUNS $10.62
- Revenue Growth
- PROK N/A
- SUNS 1342.10
- 52 Week Low
- PROK $0.68
- SUNS $8.11
- 52 Week High
- PROK $4.44
- SUNS $15.74
- Technical
- Relative Strength Index (RSI)
- PROK 21.04
- SUNS N/A
- Support Level
- PROK $0.87
- SUNS N/A
- Resistance Level
- PROK $1.00
- SUNS N/A
- Average True Range (ATR)
- PROK 0.10
- SUNS 0.00
- MACD
- PROK -0.01
- SUNS 0.00
- Stochastic Oscillator
- PROK 3.98
- SUNS 0.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.